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OBJECTIVE — To investigate if oral glutamine ameliorates exercise and postexercise night-
time hypoglycemia in type 1 diabetic adolescents.
RESEARCHDESIGNANDMETHODS — Tenadolescents(15.21.4years[SD],A1C
6.9  0.9%) on insulin pumps were studied. The subjects were randomized to receive a glu-
tamine or placebo drink pre-exercise and at bedtime (0.25 g/kg/dose). A 3:00 P.M. exercise
session consisted of four 15-min treadmill/5-min rest cycles. Pre-exercise blood glucose was
140–150 mg/dl and was monitored throughout the night. Studies were randomized crossover
over 3 weeks.
RESULTS — Blood glucose levels dropped comparably (52%) during exercise on both days.
However, the overnight number of hypoglycemic events was higher on glutamine than placebo
(70 mg/dl, P  0.03 and 60, P  0.05). The cumulative probability of nighttime hypogly-
cemia was increased on glutamine days (80%) versus placebo days (50%) (P  0.02).
CONCLUSIONS — Glutamine increased the cumulative probability of postexercise over-
night hypoglycemia compared with placebo in adolescents with type 1 diabetes. Whether glu-
tamine may enhance insulin sensitivity postexercise requires further study in type 1 diabetes.
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e observed a higher incidence of
hypoglycemia during exercise
and during the night following
exercise versus after a sedentary day in
adolescentswithtype1diabetes(1,2).Al-
though hypoglycemia decreased by dis-
continuing the insulin pump during
exercise, signiﬁcant rebound hyperglyce-
mia was observed (3).
Glutamine,thebody’smostabundant
free amino acid, is thought to regulate in-
testinal protein synthesis and be a major
source of carbon for gluconeogenesis (4).
However, conﬂicting reported data sug-
gest it can impair or accelerate recovery
from hypoglycemia (5–7). In this pilot
study we investigated if oral glutamine
could ameliorate hypoglycemia during
exercise and in the nighttime after exer-
cise in children with type 1 diabetes.
RESEARCH DESIGN AND
METHODS— Written consent was
obtained after approval by the Wolfson
Children’s Hospital Institutional Review
Committee. Ten adolescents (ﬁve boys
and ﬁve girls; mean [SD] age 15.2  1.4
years) with type 1 diabetes on insulin
pump therapy were recruited. Mean dia-
betes duration was 6.2  3.3 years; A1C,
6.9  0.9%; with normal BMI, 76.9 
12.2percentile.Subjectswereonnoother
medications or dietary supplements.
Design
Regular dietary intake was maintained for
at least 3 days prior to each admission to
the clinical research center (CRC) and di-
abetes was managed as routine. Subjects
were admitted mid-day, an intravenous
line was placed, and blood glucose was
titrated(mid100mg/dl)priorto3:00 P.M.
exercise. Children were randomized to
receive a drink containing glutamine or
placebo (PL, calorie- and nitrogen-free)
beforeexerciseandatbedtime(0.25g/kg/
dose). Patients and CRC staff were
blinded to the type of drinks consumed.
Sessions consisted of four 15-min tread-
mill cycles (heart rate 140 bpm) with
5-min rest breaks when blood glucose
concentrations were checked for a total of
75 min. If blood glucose was 60 mg/dl,
subjects consumed 15–30 g of carbohy-
drate and were not allowed back on the
treadmill until blood 70 mg/dl. Insulin
basal rates were continued during exer-
cise. Afterward, subjects ate a snack and
then dinner. Blood glucose was moni-
tored hourly overnight from 8:00 P.M.t o
8:00 A.M. Blood glucose 60 mg/dl
prompted treatment with an oral carbo-
hydrate; treatment was repeated as
needed until 80 mg/dl. Fasting glu-
tamine and ammonia concentrations
weremeasured16-hpost-exercisethefol-
lowing morning. Subjects were dis-
charged after breakfast and returned
within3weeksforanidenticalstudywith
either placebo or glutamine. The caloric/
protein intake of the two CRC days
was identical; visits were randomized
crossover.
Assays
Blood glucose concentrations were mea-
sured with a Freestyle meter (Abbott Di-
abetesCare,Alameda,CA)andbyglucose
oxidase methods with a Beckman glucose
analyzer (Beckman, Brea, CA). Plasma
glutamine concentrations were measured
by gas chromatography–mass spectrome-
try and ammonia using an automated
chemistry analyzer.
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During exercise, hypoglycemia was con-
sideredifbloodglucosewas70mg/dl;if
treated, the most recent previous blood
glucose was carried forward1hi nt h e
calculations. Repeated-measures regres-
sion models were performed to compare
glutamine concentrations and glucose
values prior to exercise and the percent-
age drop during exercise, the overnight
mean glucose, and the percentage of the
hypoglycemic values of each visit. Rank
scores (van der Waerden) were used to
normalize skewed distributions. The pro-
portions of subjects developing hypogly-
cemia during exercise on both visits were
comparedusingapermutationtestaswas
the time from 10:00 P.M. until the ﬁrst
laboratory glucose value 70 mg/dl on
the2days;allanalyseswerecontrolledfor
a visit effect. SAS version 9.1 (SAS Insti-
tute,Cary,NC)andtwo-sidedttestswere
used.
RESULTS— Plasma glutamine con-
centrations were 50% higher the morn-
ing after glutamine administration (316
mol/l) as compared with placebo (200
mol/l, P  0.001).
Exercise
Mean blood glucose concentrations prior
to exercise were comparable on the glu-
tamine and placebo day (143  31 mg/dl
vs.16254,respectively;P0.44)with
a similar percentage drop from baseline
during exercise of 52  15% glutamine
versus 52%  9% placebo (P  0.84).
There was a comparable number of sub-
jectsthatdevelopedhypoglycemiaduring
exercise on the glutamine (n  6) or pla-
cebo day (n  7).
Overnight
Mean nighttime postexercise low-glucose
levels (70 mg/dl or 60 mg/dl) were
more frequent after glutamine than after
placebo (70 mg/dl: glutamine, 19%;
placebo, 15%; P  0.03; and 60 mg/dl:
glutamine, 7.7%; placebo, 3.6%; P 
0.05). The cumulative probability of
overnighthypoglycemiawasincreasedon
the glutamine day (80%) compared with
the placebo day (50%, P  0.02) (Fig. 1).
Safety
Glutamine is tasteless and odorless, so it
was well tolerated. Plasma ammonia con-
centrations the morning after the studies
were similar (glutamine: 40.2  15.3
mol/l;placebo:41.216.1mol/l,P
NS).
CONCLUSIONS— The pilot study
datasuggestthatglutaminesupplementa-
tion increases the likelihood of nighttime
hypoglycemia in adolescents with type 1
diabetes after performing heavy exercise.
Morning glutamine concentrations
16-h post-exercise were 50% higher
during the glutamine day versus the pla-
cebo day, however these concentrations
were still below normal compared with
healthy, age-matched control subjects or
adolescents with type 1 diabetes mea-
sured at rest (P  0.001) (8) and similar
to those of healthy adults after prolonged
exercise (9). It is possible that glutamine
is low due to increased use in glucone-
ogenesis or use as a buffer or due to
increased cortisol secretion, which en-
hances splanchnic glutamine utilization
(10).Thisrelativeglutaminedepletionaf-
ter exercise requires further study.
In our study, glutamine did not affect
blood glucose levels during exercise but
increased the cumulative probability of
nighttime hypoglycemia post-exercise.
Indirectevidencesuggestsglutaminemay
indeed enhance insulin sensitivity in
other experimental and clinical situations
associated with insulin resistance includ-
ing in the intensive care unit with trauma
patients (11,12) and in children with
cystic ﬁbrosis on growth hormone (13).
Glutamine increased insulin signaling/
sensitivity in skeletal muscle in experi-
mental animals (14), and oral glutamine
increased nonoxidative glucose disposal
in healthy exercising subjects (15).
Our pilot study, however, has several
limitations including its small sample
size, the low concentrations of glutamine
achieved, and no direct measurement of
insulinsensitivity.Theseresultsarenone-
theless intriguing as the investigation of
nutritional, nonpharmacological avenues
to improve diabetes control is important
anddeservesfurtherstudy,particularlyin
teenagers who have increased insulin re-
sistance. In the aggregate, these data are
congruent with the positive effect of glu-
tamine on insulin sensitivity.
In conclusion, oral glutamine admin-
istration was associated with a higher
incidence of nighttime post-exercise hy-
poglycemia as compared with placebo in
a pilot group of adolescents with type 1
diabetes. Whether glutamine supplemen-
tationaffectsperipheraland/orhepaticin-
sulin sensitivity requires further study in
children with type 1 diabetes.
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